BioVision is a global supplier of life science research tools including biochemical and cell-based assay kits, recombinant proteins, antibodies, and enzymes for research, diagnostics, and drug discovery applications. Founded in 1999 and based in Milpitas, California, BioVision serves the biopharma, diagnostic, and academic research communities across more than 60 countries.
BioVision has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
1999
Employees
70+
Gordon Yan
Co-Founder & CEO
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Abcam
Abcam is the parent company that acquired BioVision in 2021. Global leader in life science research tools and reagents.
Cell Signaling Technology
Developer of antibodies, proteins, assay kits, and other research reagents for life sciences
Enzo Biochem
Life sciences company producing biochemical assays, molecular diagnostics, and research reagents
Bio-Rad Laboratories
Developer of life science research products including assays, antibodies, and proteins
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.